Structural Impact of the E113Q Counterion Mutation on the Activation and Deactivation Pathways of the G Protein-coupled Receptor Rhodopsin  by Standfuss, Jörg et al.
doi:10.1016/j.jmb.2008.04.055 J. Mol. Biol. (2008) 380, 145–157
Available online at www.sciencedirect.comStructural Impact of the E113Q Counterion Mutation on
the Activation and Deactivation Pathways of the G
Protein-coupled Receptor Rhodopsin
Jörg Standfuss1†, Ekaterina Zaitseva2†, Mohana Mahalingam2
and Reiner Vogel2⁎
1Structural Studies Division,
MRC Laboratory of Molecular
Biology, Hills Road, Cambridge
CB2 0QH, UK
2Arbeitsgruppe Biophysik,
Institut für Molekulare Medizin
und Zellforschung,
Albert-Ludwigs-Universität
Freiburg, Hermann-Herder-Str.
9, 79104 Freiburg, Germany
Received 14 December 2007;
received in revised form
12 March 2008;
accepted 21 April 2008
Available online
30 April 2008*Corresponding author. E-mail addr
reiner.vogel@biophysik.uni-freiburg
† J.S. and E.Z. contributed equally
Abbreviations used: GPCR, G pro
FTIR, Fourier-transform infrared; PS
base; SB, deprotonated Schiff base; H
helix; EC, extracellular loop; PC, ph
DDM, dodecyl maltoside; HOOP, hy
H/D, hydrogen/deuterium.
0022-2836/$ - see front matter © 2008 EDisruption of an interhelical salt bridge between the retinal protonated Schiff
base linked to H7 and Glu113 on H3 is one of the decisive steps during
activation of rhodopsin. Using previously established stabilization strate-
gies, we engineered a stabilized E113Q counterion mutant that converted
rhodopsin to a UV-absorbing photoreceptor with deprotonated Schiff base
and allowed reconstitution into native-like lipid membranes. Fourier-
transform infrared difference spectroscopy reveals a deprotonated Schiff
base in the photoproducts of the mutant up to the active state Meta II, the
absence of the classical pH-dependent Meta I/Meta II conformational equi-
librium in favor of Meta II, and an anticipation of active state features under
conditions that stabilize inactive photoproduct states inwildtype rhodopsin.
Glu181 on extracellular loop 2, is found to be unable tomaintain a counterion
function to the Schiff base on the activation pathway of rhodopsin in the
absence of the primary counterion, Glu113. The Schiff base becomes pro-
tonated in the transition to Meta III. This protonation is, however, not asso-
ciated with a deactivation of the receptor, in contrast to wildtype rhodopsin.
Glu181 is suggested to be the counterion in the Meta III state of the mutant
and appears to be capable of stabilizing a protonated Schiff base in Meta III,
but not of constraining the receptor in an inactive conformation.© 2008 Elsevier Ltd. All rights reserved.Keywords: infrared spectroscopy; membrane protein; visual pigment; G
protein-coupled receptor; signal transductionEdited by B. HonigIntroduction
The visual pigment rhodopsin is by far the best
characterized member of the family of G protein-
coupled receptors (GPCRs).1 In contrast to other
GPCRs, rhodopsin is not activated by diffusible
ligands, but by photoisomerization of its retinal
chromophore, which is covalently bound to Lys296
on H7 in the transmembrane domain of the proteiness:
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lsevier Ltd. All rights reserveby a protonated Schiff base. This isomerization from
11-cis to all-trans switches the light-sensing ligand
from an inverse agonist to a full agonist and triggers
the activation of the receptor. Rhodopsin offers the
unique possibility of using light as a trigger to
explore the single steps of the activation of a GPCR
on a molecular level by a variety of biophysical
methods. It allows interpretation of the data on the
basis of solid crystallographic structures, which are
available for the dark state,2–5 and for some of the
inactive photo intermediates,6,7 despite the fact that
a reliable crystal structure of the active state, Meta II,
is still lacking.
The inactive conformation of the dark state is sta-
bilized mainly by two constraints; namely, by the
geometry of the 11-cis ligand and by a salt bridge in
the transmembrane part of the receptor. This salt
bridge is formed between the protonated retinal
Schiff base (PSB) and a protein counterion consisting
of Glu113 on transmembrane helix H3,8–10 which
appears to be further stabilized by the negatived.
146 Rhodopsin E113Q Counterion Mutantcharge of Glu181 on the extracellular loop 2 (EC2)
(Fig. 1).11 After photoisomerization of the chromo-
phore, the receptor evolves through a series of
inactive photointermediates, Batho, BSI, Lumi, and
Meta I, which are accessible in time-resolved or cryo-
trapping experiments, to the active state Meta II.
During this evolution, the salt bridge to the PSB is
weakened and the function of the counterion shifts
gradually fromGlu113 to Glu181 in the transitions to
Lumi and Meta I.11,12 It is broken in the conforma-
tional transition to Meta II by a proton transfer from
the PSB to Glu113,13 leading to a deprotonated re-
tinal Schiff base (SB) in Meta II and a shift of the
absorption maximum from the visible range to
380 nm. The transition from inactive Meta I to Meta
II further involves uptake of a solute proton by a
cytoplasmic group,14 which renders the conforma-
tional equilibrium between Meta I and Meta II pH-
dependent.15 These two protonation switches are
coupled during rhodopsin activation and this
coupling was shown to be mediated by certain
groups of the all-trans retinal ligand, such as the 9-
methyl group on the polyene and the ionone ring.16
The PSB-Glu113 salt bridge of rhodopsin or the
corresponding salt bridge between Lys296 and
Glu113 in the ligand-free apoprotein opsin17 are not
unique to rhodopsin or to the family of visual pig-
ments. In the α1b adrenergic receptor, a homologous
salt bridge between an aspartate on H3 and a lysine
on H7 stabilizes the inactive receptor conformation
and is required for constricting the basal activity of
the receptor to a low level.18 It is broken during ago-
nist-induced receptor activation by interaction of the
aspartate with the protonated amine of the catecho-
lamine ligand.19 In the δ opioid and the angiotensinFig. 1. Molecular structure of the dark state of rhodopsin. T
with the engineered disulfide bridge between residues 2 and 28
the extracellular loop 3. Close-ups show the hydrogen-bonde
Glu181 on EC2, the Glu122 network between H3 and H5 next t
between H1, H2, and H7, which extends further to Trp265 on H
upward).AT1 receptors interhelical interactions between H3
andH7 aremaintained betweenAsp and Tyr residues
and two Asn residues, respectively, which also con-
strain the basal activity of these receptors.20–22
Previous studies have shown that E113Q or E113A
opsin mutants are still able to bind 11-cis retinal and
to form visual pigments, but that these visual pig-
ments have a deprotonated Schiff base and hence
absorb in the near-UV around 380 nm.8 These UV-
absorbing mutants are functional and activate the
visual G protein transducin in a light-dependent
manner.9,23 A protonation of the Schiff base and a
concomitant shift of the absorption maximum to the
visible range was observed only at very low pH and
in the presence of suitable solute anions, with a
bound solute anion serving as a counterion to the
PSB.10,24
One of our main concerns in this study was to shed
light on the interplay between Glu113 and Glu181 on
EC2 during the transitions to Meta I and Meta II.
Invertebrate rhodopsins have Glu181 as a dark state
counterion and it was suggested that vertebrate rho-
dopsins acquired the Glu113 counterion at some
point during their evolution.25 Recently, a counterion
switch model was proposed for the activation path-
way of vertebrate rhodopsin.12 On the basis of Raman
data and mutational data,26 Glu181 was suggested
to be neutral in the dark state and to become charged
by proton transfer to Glu113 in the transition to the
active state precursor Meta I, thereby switching the
function of the counterion from Glu113 to Glu181.
This proton transfer hypothesis was not compatible
with Fourier transform infrared (FTIR) spectroscopic
data,27 and instead a gradual shift of the counterion
function from Glu113 to Glu181 on the activationhe model shows the helix bundle of stabilized rhodopsin
2,3 stabilizing the interaction between the N terminus and
d network extending from the Glu113/PSB salt-bridge to
o the ring of retinal, and the water-bridged Asp83 network
6 via an additional water molecule (the cytoplasmic side is
147Rhodopsin E113Q Counterion Mutantpathway was found, with Glu181 remaining charged
during the entire activation process and Glu113 be-
coming neutralized by proton transfer from the PSB
only in the final transition to active Meta II.11
In the present study, we examined the activation
and deactivation pathways of the E113Qmutant in a
native-like membrane environment. To counteract
the destabilizing effect of this mutation and to allow
reconstitution of the purified receptor into lipid
membranes, we used an E113Qmutant with an add-
itionally engineered disulfide bridge in the extra-
cellular domain, which stabilized the folded protein
without interfering significantly with receptor activ-
ation.28 The results indicate clearly that Glu181 can-
not serve as a single counterion to the PSB in the
absence of the primary Glu113 counterion on the
activation pathway of the receptor. TheMeta I/Meta
II conformational equilibrium, which is maintained
in the E181Q mutant,11 is absent from the E113Q
mutant, which features a deprotonated Schiff base in
all photoproduct states up to Meta II. A protonation
of the SB is observed only in the transition toMeta III
on the deactivation pathway of the receptor. In con-
trast to wildtype Meta III, the Meta III state of the
mutant adopts an active state conformation in a pH-
independent manner, indicating the necessity of
Glu113 for deactivation of the receptor, but not for re-
protonation of the SB, which is achieved presumably
by Glu181.Results
In this study, we used FTIR spectroscopy, which is a
method of choice for investigating the structural
changes during activation of rhodopsin due to its
excellent sensitivity for changes of both the chromo-
phore and the protein.29 Conformational changes of
the protein are sensed by the amide I vibrations of the
protein backbone, absorbing in the range 1600–
1700 cm−1, and by several protonated carboxylic
acids, which have their intense C=O stretch absorp-
tion in the spectral region 1700–1780 cm−1, and are
not crowded by other protein vibrational modes. The
position of their C=O stretch is very sensitive to hy-
drogen bonding within the surrounding functional
networks, with positions at around 1770 cm−1,
1740 cm−1, and 1710 cm−1 being indicative for a
carboxylic acid making zero, one, or two hydrogen
bonds, respectively, with its environment.30
With Asp83 and Glu122, rhodopsin has two car-
boxylic acids in its transmembrane core that take
part in two important interhelical networks of the
receptor between H1, H2, and H7, and between H3
and H5, respectively1 (Fig. 1). Both groups remain
protonated throughout receptor activation and can
serve as valuable intrinsic reporter groups for confor-
mational changes in their corresponding receptor
microdomains. Using these two reporter groups in
addition to information derived from other vibra-
tional modes, we can track the path of retinal in its
binding pocket during activation of a E113Q mutant
and compare it to that in the wildtype receptor.The stabilizing N2C/D282C mutation does not
significantly affect the activation pathway of
rhodopsin
As a detergent environment profoundly perturbs
the conformational equilibrium between Meta I and
Meta II, reconstitution of the purified receptor into
native-like lipid membranes is essential. As we an-
ticipated an E113Q mutant to be considerably less
stable thanwildtype rhodopsin, we sought strategies
to increase its stability to ensure successful recon-
stitution. A higher level of stability could prove to be
beneficial for crystallographic studies of rhodopsin's
inherently unstable active conformation. Such a stra-
tegy was devised by the introduction of two cys-
teines on the N terminus and the extracellular loop 3
in the N2C/D282C mutant, which have been shown
to form a disulfide bridge spontaneously (Fig. 1).28
This engineered disulfide bridge considerably en-
hanced the thermal stability of opsin without interfer-
ing significantly with pigment formation or pigment
activation. Additionally, a recent crystallographic
analysis of this stabilized rhodopsinmutant revealed
onlyminor impact of the engineered disulfide bridge
on the global fold of the protein.3 To further exclude
implications of the additional disulfide bridge on the
various conformational states of the receptor, we
reconstituted the N2C/D282C mutant into phos-
phatidyl choline (PC) lipidmembranes and followed
the activation pathway in the transitions from the
dark state to the Lumi, Meta I, and Meta II photo-
product states using FTIR difference spectroscopy
(Fig. 2). The resulting difference spectra are very
similar to those obtained fromwildtype rhodopsin in
parallel. In particular, the band patterns in the con-
formationally sensitive range of the amide I vibra-
tions around 1650 cm−1 and of the C=O stretch of
protonated carboxylic acids between 1700 cm−1 and
1770 cm−1 are essentially identical. In the transition to
theMeta II state, the band pattern due to the hydrogen
bonding changes of Asp83 and Glu122 can be
observed, leading to a shift of their absorption from
1768 cm−1 and 1728 cm−1, respectively, in the dark
state (negative) to a combined Meta II band (positive)
at 1748 cm−1. Likewise, proton transfer from the PSB to
Glu113 leads to the 1712 cm−1 band of protonated
Glu113 in Meta II both in the mutant and wildtype.
Therefore, the additional disulfide bond between resi-
dues 2 and 282 in N2C/D282C, which is responsible
for the reported stabilization, does not interfere signi-
ficantly with the activation pathway of the receptor.
The E113Qstab mutant forms a pH-dependent
equilibrium between SB and PSB forms
In preliminary experiments, activation of the triple
mutant N2C/D282C/E113Q (from hereon E113Qstab)
was tested in the presence of the detergent dodecyl
maltoside (DDM). Meta II minus dark state FTIR
difference spectra of E113Qstab correspond to pre-
viously published spectra of the (unstabilized) E113A
mutant in detergent,13 confirming band assignments
and results derived in that study also for E113Qstab.
Fig. 2. The stabilizing disulfide bridge in the N2C/
D282C mutant does not significantly alter the transition
from the dark to the photoproduct states. The light-induced
transitions of lipid-membrane reconstituted wildtype rho-
dopsin (gray spectra) and N2C/D282C mutant (black
spectra) from the dark state to Lumi (stabilized at -90 °C,
pH 7.0),Meta I (at −20 °C, pH 7.0), andMeta II (at 10 °C, pH
5.0) reveal essentially identical FTIR difference spectra. This
holds in particular in the structurally informative range of
protonated carboxylic acids between 1700 cm− 1 and
1770 cm−1, and in the amide I range of backbone vibrations
around 1650 cm−1.
Fig. 3. pH- and anion-dependent protonation state of
the Schiff base in E113Qstab. UV-visible spectra of the
E113Qstab mutant reconstituted into PC lipid membranes
show an absorption maximum at 382 nm at pH 7.5 in the
absence of NaCl, indicating a deprotonated retinal Schiff
base. At pH 5.0 in the presence of additional 100 mM
NaCl, the absorption maximum is shifted to ∼493 nm,
indicating a protonated Schiff base.
148 Rhodopsin E113Q Counterion MutantIn order to investigate the properties of E113Qstab
in a more native-like membrane environment, the
pigment was reconstituted from DDM into PC bila-
yers. Similar to the (unstabilized) E113Q pigment in
detergent,8,9 E113Qstab in membranes forms in the
dark an equilibrium between a UV-absorbing form
with a deprotonated Schiff base, E113Qstab SB (λmax
at ∼382 nm), and a species with protonated Schiff
base, E113Qstab PSB (λmax at ∼493 nm). In the
absence of chloride, only the SB species is observed
at neutral to alkaline pH. At pH 5.0, some contribu-
tion of the PSB species is observed, which can be
increased considerably by the addition of small
amounts of chloride. At pH 5.0 in the presence of
100 mM NaCl, this protonation equilibrium is fully
shifted to the side of the PSB form (Fig. 3). This
chloride dependence is in full agreement with
previous studies of the purified (unstabilized)
E113Q mutant,10,24 indicating that the stabilizing
disulfide bridge in E113Qstab does not interfere with
these functional implications of the E113Qmutation.
On the basis of these initial experiments, we pre-
pared E113Qstab SB at pH 7.5 in the absence of NaCl
and E113Qstab PSB at pH 5.0 in the presence of
100 mM NaCl.
The Meta II state of E113Qstab
E113Qstab PSB and E113Qstab SB were activated at
10 °C by brief illuminations with orange light(N530 nm) or 395 nm light from a UV-emitting
LED, respectively. Under both conditions, an active
Meta II state was formed that revealed the con-
formational signatures of native Meta II in the FTIR
difference spectra (Fig. 4). Additional experiments
further confirmed the capability of the activated mu-
tant to interactwithGprotein-derived peptides (data
not shown).
In theMeta IIminus dark state difference spectrum
of E113Qstab PSB (Fig. 4a), some of the dark state
chromophore bands are somewhat downshifted as
compared with wildtype, as for example the finger-
print mode at 1226 cm−1 or the hydrogen-out-of-
plane (HOOP)mode at 960 cm−1. The intensity of the
positive fingerprint mode in Meta II at 1197 cm−1
indicates that there is a partial protonation of the
Schiff base in the Meta II state of E113Qstab under
these conditions, presumably due to persistent bin-
ding of chloride in the retinal-binding pocket of the
mutant in Meta II, a behavior found also, to a lesser
extent, in native Meta II.31 In native pigment, the
protonation of Glu113 during the transition to Meta
II causes a negative band at 1391 cm−1 for the sym-
metric COO− stretch of the glutamate in the dark
state and a positive band at 1712 cm−1 for the C=O
stretch of the glutamic acid in Meta II,13 which are
absent from the mutant. In E113Qstab there is,
however, positive (Meta II) absorption at around
1700 cm−1, which also compensates the negative
band in wildtype at 1695 cm−1. A contribution of a
carboxylic acid to this band can be excluded from its
lack of hydrogen/deuterium (H/D) sensitivity (data
not shown). The conformationally sensitive band
pattern of Asp83 and Glu122 in the range between
1720 cm−1 and 1770 cm−1 is similar to the wildtype.
The Meta II state of E113Qstab SB has a deproto-
nated Schiff base. The Meta II minus dark state FTIR
difference spectrum differs from that of E113Qstab
PSB due mainly to the considerably reduced inten-
sity of chromophore bands, which have little IR in-
Fig. 5. Difference spectra of a cryo-trapped Meta II
precursor state of the E113Qstab mutant. Light-induced
photoproduct minus dark state FTIR difference spectra
of the E113Qstab mutant were recorded at −30 °C for
E113Qstab PSB (red spectra in a and b) and E113Qstab SB
(blue spectrum in b) in lipid membranes and are compared
to wildtype Meta I minus dark state difference spectra
recorded at the same temperature. Similarly to the Meta II
difference spectra shown in Fig. 4, deprotonation of the
Schiff base in the SB form of E113Qstab reduces the intensity
of chromophore-related bands. The Meta II precursor
states of both the SB and the PSB forms of themutant reveal
a band pattern of Asp83 and Glu122 between 1720 cm−1
and 1770 cm−1 that is entirely different from that observed
in wildtypeMeta I andmuchmore similar toMeta II. Also,
theMeta IHOOPmode at 951 cm− 1 is lacking in the −30 °C
photoproduct of E113Qstab PSB.
Fig. 4. Meta II difference spectra of the E113Qstab
mutant. Light-induced Meta II minus dark state FTIR
difference spectra are shown for wildtype rhodopsin (gray
spectrum in a) and for the E113Qstab mutant in its form
with protonated Schiff base (E113Qstab PSB, red spectra in a
and b) and deprotonated Schiff base (E113Qstab SB, blue
spectrum in b) in lipidmembranes. Both protonation states
of the mutant pigment form Meta II states with overall
features similar to wildtype Meta II, despite the fact that
chromophore related bands are partly shifted in the dark
state of E113Qstab PSB. Several of these bands have only
low intensity or are entirely lacking in the dark state of
E113Qstab SB due to the reduced charge alternation of the
retinal polyene. Meta II spectra were obtained at 10 °C.
149Rhodopsin E113Q Counterion Mutanttensity when the retinal Schiff base is deprotonated
due to the resulting reduced charge alternation along
the polyene (Fig. 4b). This is particularly noticeable for
the dark stateHOOPmodeat 960 cm−1, the 1226 cm−1
fingerprint mode, and the 1546 cm−1 ethylenic mode
of the chromophore. Further alterations in the range
around 1650 cm−1 for both E113Qstab SB and PSB
might be accounted for by different positions of
the Schiff base C=N stretch mode in the different
states.32
The absence of the counterion function of
Glu113 in E113Qstab abolishes the
pH-dependence of Meta I/Meta II
The pH-dependence of Meta I/Meta II,15 which
reflects the proton uptake of rhodopsin during its
transition to Meta II and is one of the hallmarks of
activation of rhodopsin, is absent from E113Qstab.
Starting from the deprotonated form of E113Qstab,
we investigated a putative pH-dependence in form-
ation of Meta II both at 10 °C and −10 °C, which was
clearly absent from the accessible pH range up to pH
9, revealing Meta II states at all pH values similar to
those shown in Fig. 4b. In contrast to wildtype rho-
dopsin or the E181Q mutant,11 E113Qstab does there-
fore not have a Meta I state that can be stabilized
solely by alkaline pH.Lack of the Glu113 counterion alters the Meta II
precursor state of E113Qstab
In order to examine the structural properties of
Meta II precursor states of the counterionmutant, the
photoreaction of E113Qstab was investigated at lower
temperature, allowing the cryo-trapping of a Meta II
precursor at −30 °C (Fig. 5). Under these conditions,
wildtype rhodopsin produces the inactive Meta I
state. Due to the considerable structural differences
between this cryo-trapped intermediate of the mu-
tant and native Meta I, we refer to this state as the
Meta II precursor state. Similar toMeta I in wildtype,
it links the Lumi state of the mutant with its Meta II
state (see Fig. 6c and d).
This cryo-trapped Meta II precursor state of
E113Qstab PSB (Fig. 5a) has a fully protonated Schiff
base, as evident from the strong intensity of the
1202 cm−1 fingerprint mode of the chromophore. The
lack of the Meta I HOOP mode at 951 cm−1 indicates
a chromophore with an essentially planar polyene in
contrast to wildtype Meta I. In the amide I range, the
cryo-trappedMeta II precursor state of E113Qstab PSB
shows pronounced positive bands at 1632 cm−1 and
1648 cm−1, which merge at higher temperature into
the Meta II marker band at 1644 cm−1. The Meta I
amide marker band of wildtype at 1663 cm−1, on the
other hand, is completely lacking in the mutant. In
the range of the protonated carboxylic acids, we
Fig. 6. Evolution of structural changes in the Asp83 and
Glu122 networks during activation of wildtype rhodopsin
and counterion mutants. FTIR difference spectra of the
transitions from the dark state to Lumi (gray), Meta I (blue),
and Meta II (red) are compared for wildtype rhodopsin (a),
the E181Qmutant (b, reproduced from ref. 10), and the PSB
(c) and SB (d) forms of E113Qstab. These spectra allow us to
monitor the changes in the hydrogen bonded networks
around Asp83 (green) and Glu122 (purple) and of amide I
marker bands of Meta I and Meta II at 1663 cm−1 and
1644 cm−1, respectively. The downshift of Asp83, which is
observed in wildtype only in the transition to Meta II, is
observed partly in Meta I of E181Q and fully in the
photoproduct states at −30 °C of E113Qstab PSB and SB, as
evident from the intensity of the negative peak of Asp83 in
the respective dark states. Glu122, which in wildtype is
transiently downshifted in Meta I and upshifted in Meta II,
experiences in the E113Qstab mutants a Meta II-like upshift
already partly in the Meta II precursor state at −30 °C.
150 Rhodopsin E113Q Counterion Mutantobserve in wildtype a downshift of the band of
Glu122 from a doublet at 1735 cm−1 and 1728 cm−1 in
the dark state to 1704 cm−1 (in a broader shoulder),
indicating a strengthening of its hydrogen bonding in
its interhelical network with His211 and Trp126 (see
Figs. 1 and 6). Conversely, in the cryo-trappedMeta II
precursor state of E113Qstab PSB, Glu122 is upshifted
by about half of of its upshift in Meta II, indicating a
partial disruption of its hydrogen bonding in this
precursor state. Asp 83, which undergoes only slight
changes in the transition to Meta I in wildtype, expe-
riences in E113Qstab a downshift from 1768 cm
−1 to
1753 cm−1 comparable to that in Meta II, indicating a
full rearrangement of the involved H1/H2/H7 net-work to an active state conformation in this Meta II
precursor state at −30 °C.
The cryo-trappedMeta II precursor state of E113Qstab
SB (Fig. 5b) maintains its deprotonated Schiff base
and therefore again lacks intensity in the chromo-
phore bands due to the lack of charge alternation
along the SB chromophore. The presence of an SB in
this state was also verified using UV-visible spectro-
scopy (data not shown). Conformationally sensitive
bands of amide I vibrations and carboxylic acids are
very similar to the Meta II precursor state of the PSB
form of E113Qstab, despite a slightly smaller upshift
of the position of Glu122.
The Meta III states on the deactivation pathways
of wildtype rhodopsin and E113Qstab SB
In wildtype rhodopsin, the active state conforma-
tion of Meta II decays in the transition to Meta III,
which is triggered by a thermal isomerization of the
Schiff base C15=N double bond from all-trans 15-
anti to all-trans 15-syn.33 This deactivation step can
likewise be triggered by UV-illumination of theMeta
II state.34 The transition to Meta III involves a re-
protonation of the SB and a shift of the absorption
maximum to 470 nm (Fig. 7a). As shown earlier, the
transition to Meta III regularly involves a deactiva-
tion of the receptor at neutral to alkaline pH, while
at pH 4.0, Meta III adopts an active conformation
similar to that of Meta II.35
In E113Qstab SB, photolysis of the UV-absorbing
pigmentwith a short (1 s) UV light pulse converts the
dark state of the mutant to its Meta II state, which is
slightly blue-shifted as compared to the dark state
(Fig. 7b), in agreement with time-resolvedUV-visible
studies.36 Further UV illumination of this Meta II
state for 20 s converts Meta II to a photoproduct with
PSB absorbing at 470 nm, similar as observed above
for wildtype rhodopsin.
The quantum yield of the secondary reaction from
Meta II to Meta III is astonishingly high. The 1 s
illumination photo-converts about 40–50% of the
dark state (see below), of which ∼80% are present as
Meta II, while 20% were further photo-converted to
Meta III, as evident from the small absorption in-
crease at 470 nm in the red spectrum of Fig. 7b. The
quantum yield of this secondary reaction is therefore
roughly half of that of the primary reaction. In order
to avoid complications with the partially protonated
Schiff base of Meta II of E113Qstab PSB, we focus on
the Meta III state of E113Qstab SB stabilized in the
absence of solute chloride.
FTIR characterization of Meta III of E113Qstab SB
In Fig. 8a, the light-induced Meta III formation of
E113Qstab SB is monitored in theMeta III minus dark
state FTIR difference spectrum (blue) under condi-
tions identical with those in Fig. 7b, which is com-
pared with the Meta II minus dark state (red) differ-
ence spectrum obtained by brief illumination. While
the 20 s illumination used to produce Meta III is suf-
ficient to establish a photo-stationary state, the first
Fig. 7. The transition to the Meta III state of E113Qstab
SB involves a protonation of the Schiff base. (a) The dark
state of wildtype rhodopsin (λmax 500 nm) is converted by
orange illumination (N530 nm) to Meta II (380 nm), which
can be converted to Meta III (470 nm) by UV illumination
(∼395 nm). (b) The dark state of E113Qstab SB (382 nm) is
converted by a 1 s UV light pulse to Meta II, which is
slightly blue-shifted. Extended UV-illumination (20 s) con-
verts Meta II to Meta III, involving protonation of the Schiff
base and an absorption shift to ∼470 nm, similar to the
wildtype. This protonation of the Schiff base of E113Qstab
SB indicates a counterion different from Glu113 in the Meta
III state. As evident from the slight absorption increase at
470 nm in the red spectrum, a small amount of Meta III is
formed during the first 1 s UV light pulse. Experiments
were performed at 10 °C and pH 5.0 in the case of wildtype
and at pH 7.5 in the case of E113Qstab SB, tickmarks
correspond to 50 mOD.
Fig. 8. The Meta III state of E113Qstab adopts an active
state conformation. (a) The conversion of the dark state of
E113Qstab SB to its Meta II andMeta III states was achieved
as in Fig. 7 at 10 °C and pH 7.5 by a sequence of short and
long periods of UV illumination and followed in FTIR
difference spectraMeta II minus dark state in red andMeta
III minus dark state in blue. Spectra were normalized to
account for differing pigment conversion. As evident from
the similarity of the spectra in the conformationally sen-
sitive range between 1600 cm− 1 and 1800 cm− 1, theMeta III
state of E113Qstab retains the active state conformation of
Meta II. The strong band at 1565 cm−1 is the ethylenic C=C
stretch of the Meta III chromophore, reflecting the pro-
tonation of the Schiff base. The Meta III minus Meta II
difference spectrum of E113Qstab (gray) corresponds in
many aspects to that of wildtype (green) obtained at pH
4.0, where the active conformation of Meta III is stabilized,
with some differences in the range between 1600 cm− 1 and
1700 cm−1. (b) The signature of the all-trans 15-syn chro-
mophore of Meta III in E113Qstab is identified in Meta III
minus Meta II difference spectra of E113Qstab obtained in
H2O (red) and
2H2O (blue). This signature consists of an
NH bending mode at 1345 cm− 1 coupled to the C14–C15
stretch modes at 1175 cm− 1 and 1158 cm− 1 in H2O, and
aN50 cm− 1 upshift of the latter to 1238 cm− 1 in 2H2O,
where this coupling is absent. A very similar signature is
observed for Meta III of wildtype, which is shown here
again for the active Meta III conformation adopted at pH
4.0.35
151Rhodopsin E113Q Counterion Mutant1 s UV light pulse to produce mainly Meta II leads to
pigment conversion of only 40∼50%. The spectra in
Fig. 8a were therefore normalized for easier compar-
ison using band patterns of the dark state. As evident
from the almost identical band pattern in the con-
formationally sensitive range between 1600 cm−1
and 1800 cm−1, Meta III of the mutant adopts an
active state protein conformation very similar to that
of Meta II. Note that the photoproduct state in the
Meta III minus dark state spectrum presumably still
contains residual Meta II, as indicated by the small
absorption peak at 380 nm remaining in the blue
spectrum of the photostationary state in Fig. 7b.
However, this does not alter the above conclusion.
By subtracting the Meta II minus dark state spec-
trum from the Meta III minus dark state spectrum,
we obtain the Meta III minus Meta II difference
spectrumof themutant (Fig. 8a, gray spectrum). This
spectrum is very similar to the corresponding double
difference spectrum of wildtype (green spectrum)
152 Rhodopsin E113Q Counterion Mutantobtained under conditions where wildtype Meta III
adopts a similarly active conformation (pH 4.0).35
The mutant spectrum reveals a pronounced Meta III
band at 1565 cm−1 of the ethylenic C=C stretch
mode of the chromophore, reflecting the protonation
of the SB in Meta III, and a series of other chro-
mophore bands between 1100 cm−1 and 1400 cm−1
being indicative of the isomerization of the Schiff
base to 15-syn, which is addressed below. As seen in
the wildtype spectrum, there is a slight decrease of
the absorption of the protonated carboxylic acid
Glu122 (H3) at 1747 cm−1, which is positioned next
to the ring of retinal. This residue is therefore slightly
altered by the C15=N isomerization of the chromo-
phore, but retains its overall Meta II-like absorption
pattern. Slight changes in the band pattern between
1600 cm−1 and 1700 cm−1 in themutant as compared
to wildtype are due, in part, to contributions of the
amide absorption of the glutamine at position 113 in
the mutant.
The all-trans 15-syn isomer can be identified by the
strong coupling between the C14–C15 stretching
modes and the Schiff base NH bending mode in a
15-syn PSB,37 which is abolished in 2H2O, leading to a
very pronounced upshift of the C14–C15 modes by
more than 50 cm−1.33 Comparison of the Meta III
minus Meta II difference spectrum of E113Qstab SB
with that of wildtype (again for the active conforma-
tion of wildtype Meta III stabilized at pH 4.0) reveals
almost identical positions of the NH bendingmode at
1345 cm−1 (Fig. 8b). The C14–C15 stretch absorbs at
1175 cm−1 and 1158 cm−1 in H2O, and experiences a
pronounced upshift to 1238 cm−1 in 2H2O. The vibra-Fig. 9. The Glu113/PSB salt bridge is responsible for
receptor deactivation in the transition to Meta III. (a) Meta
IIIminus dark state FTIRdifference spectrawere generated
by orange and UV illumination in the case of wildtype
rhodopsin or by a single 20 s UV illumination in the case of
theUV-absorbing E113Qstabmutant at 10 °C at different pH
values. (b) Meta III of wildtype rhodopsin shows a pH-
dependent transition from an activeMeta II-like conforma-
tion at extremely acidic pH to an inactive conformation at
neutral pHwith an apparent pKA of 4.7 as reported.
35 This
pH-dependent transition is followed here by monitoring
the intensity of the active statemarker band at 1644 cm− 1 in
Meta IIIminus dark state difference spectra, normalized by
its intensity in Meta II minus dark state reference spectra.
Meta III of the E113Qstab mutant, on the other hand, per-
sists in the active conformation also in the very alkaline pH
range. Re-formation of the salt bridge between the PSB and
Glu113 is therefore responsible for the deactivation of the
receptor in the transition to Meta III at neutral to alkaline
pH. (c) In this cartoon of the retinal-binding pocket of the
Meta III states of wildtype rhodopsin, the inactive confor-
mation of Meta III is stabilized by the structural salt bridge
between the PSB and Glu113, which keeps the retinal in a
position similar as in the inactive dark state orMeta I. In the
active conformation of Meta III the PSB is translocated
along the long axis of retinal away from Glu113 toward
Glu181, similar as reported previously for Meta II.38 This
allows for formation of a salt bridge with Glu181, which
stabilizes the PSB but does not constrain the receptor in
an inactive conformation (the cytoplasmic side points
upward).tional modes containing C14–C15 contributions have
been identified in wildtype using 13C isotopic labe-
ling of C14–C15,33,35 the H/D-sensitive band at
1133 cm−1 being unresponsive to the labeling.
The receptor conformation in Meta III of
E113Qstab SB and wildtype rhodopsin
Wildtype Meta III exists in a pH-dependent con-
formational equilibrium between an active confor-
mation at acidic pH and an inactive conformation at
pH 6.0 and above,35 which is evident from the FTIR
difference spectra Meta III minus dark state pro-
duced by consecutive orange and UV illuminations
(Fig. 9a). The pH-dependence of this equilibrium
can, for instance, be monitored using the intensity of
the amide I marker band of the active state confor-
mation at 1644 cm−1, revealing a titration curve
153Rhodopsin E113Q Counterion Mutantfollowing a regular Henderson–Hasselbalch curve
with an apparent pKA of 4.7 (at 10 °C) (Fig. 9b). Meta
III of the E113Qstabmutant, on the other hand, adopts
an active state conformation over the entire pH range
up to very alkaline values. This pH-independence of
the active state conformation of Meta III in the mu-
tant indicates that Glu113 is responsible for stabiliz-
ing the inactive conformation of Meta III in wildtype
by re-forming a salt bridge to the PSB.Discussion
Besides the shape of the 11-cis retinal ligand, the
salt bridge between the positively charged PSB and
its negative protein counterion, Glu113 on H3, is the
second major conformational constraint that stabi-
lizes the inactive dark state of rhodopsin and that
needs to be broken during activation of the receptor.
A similar salt bridge exists in opsin between Glu113
and Lys296 on H7 (which forms the covalent Schiff
base with retinal in the pigment),17 and between ho-
mologous residues in the α-adrenergic receptor,18
and is important for restraining basal activity of these
receptors. In rhodopsin, breaking of this salt bridge in
the transition to the signaling state, Meta II, is con-
nected with a movement of retinal along its long axis
towardH5,38 disrupting a hydrogen bonded interhelical
network of His211 with Glu122 and Trp126 on H3,39,40
and triggering via interaction with Trp26541 an out-
ward-directed rigid body movement of H6 (Fig. 1).42,43
This concertedmotion of retinal and transmembrane
helices is also coupled to conformational changes in a
hydrogen bonded interhelical network between H1,
H2, and H7, formed by Asn55 (H1), Asp83 (H2),
Asn302 (H7), and other residues, aswell as structural
water molecules.
The neutral carboxylic acids Asp83 and Glu122
participate in the H1/H2/H7 and H3/H5 micro-
domains, respectively, and serve as valuable site-spe-
cific reporter groups for infrared spectroscopy. The
stretching vibration of their C=O function absorbs in
a relatively uncrowded spectral region between
1700 cm−1 and 1780 cm−1 and is highly sensitive to
changes in their hydrogen bonding resulting from
conformational transitions in the surrounding net-
works. Using these two reporter groups, we can fol-
low the evolution of conformational changes within
the associated two microdomains during receptor
activation and correlate themwithmolecular changes
detected in other domains. In Fig. 6a, the photo-
product minus dark state FTIR difference spectra of
the transition to the inactive Lumi state trapped at
−90 °C, to Meta I trapped at −30 and at −20 °C, and
to active Meta II stabilized at 10 °C are shown for the
wildtype receptor.
Asp83 (marked green in Fig. 6) reports only very
slight changes in the H1/H2/H7 network in the
transitions from the dark state to Lumi and Meta I,
and a major change in the transition to Meta II, down-
shifting the absorption of Asp83 by approximately
20 cm−1, corresponding to the net formation of one
hydrogen bond in the rearrangement of the micro-domain in the active receptor.30 Glu122 (marked pur-
ple in Fig. 6) in the H3/H5 microdomain is in contact
with the ring of retinal and has two distinct negative
absorption peaks in the dark, probably reflecting two
different populations of ring isomers in the dark
state.44 In this state, Glu122 makes two hydrogen
bonds of intermediate strength, one to the backbone
carbonyl of His211 on H5 and an intrahelical hydro-
gen bond to the ring of Trp126 (Fig. 1).1,2,4 While this
hydrogen bonding is not altered substantially in the
transition to Lumi, it is transiently strengthened in
Meta I, leading to a downshift of the Glu122 absorp-
tion to 1704 cm−1.40 In the transition to activeMeta II,
the absorption of Glu122 is considerably upshifted to
above 1740 cm−1,45 presumably reflecting the dis-
ruption of the hydrogen bond to the backbone carbo-
nyl of His211, that is also detected by NMR.39
Turning to the E113Qstab mutant in either Schiff
base protonation form (Fig. 6c and d), neither Asp83
nor Glu122 show pronounced changes in Lumi, in-
dicating that at −90 °C re-arrangements of helices are
largely inhibited. At −30 °C, however, in the tran-
sition to aMeta II precursor state, Asp83 experiences
in E113Qstab a downshift of its absorption that is
observed in wildtype in a similar fashion only in the
transition to Meta II. The absence of the salt bridge
betweenH3 and the PSB,which is linked toH7 by the
side chain of Lys296, allows the H1/H2/H7 network
to adopt its active state conformation already in this
precursor state stabilized at −30 °C by uncoupling it
from other microdomains of the receptor. Also,
Glu122 experiences in this precursor state conforma-
tional changes very different from native Meta I.
Instead of a strengthening of its hydrogen bonding
pattern as in wildtype Meta I, we observe a weak-
ening by about half of that observed later in the
transition to Meta II. As Glu122 is in contact with the
ring of retinal, this indicates an interaction of the ring
with the H3/H5 network that is considerably altered
in this precursor state of the mutant as compared to
wildtype, and partly (∼50%) Meta II-like. This indi-
cates that a partial movement of the ligand toward
H5 occurs at −30 °C, and is responsible for this alter-
ation of the activation pattern in the mutant.
These changes in the activation pathway of the
E113Qstab mutant sensed by the Asp83 and Glu122
reporter groups are reflected in the amide I pattern of
the protein backbone. The amide I marker band of
Meta I at 1663 cm−1 (Fig. 6a) is developed only
poorly in the spectra of E113Qstab at −30 °C (Fig. 6c
and d, blue) and instead two intense amide I bands
are observed at lower wavenumbers that merge at
10 °C into theMeta II marker band complex centered
at 1644 cm−1.
It is instructive to compare this impact of muta-
tional neutralization of Glu113 with that of Glu181
on EC2. In native rhodopsin, Glu181 was proposed
to contribute in the dark state to a complex counter-
ion with Glu113,11 and was reported to assume a
major part of the counterion function in Meta I.12 In
Fig. 6b, we compare the conformational evolution of
the active state of E181Q with that of E113Qstab and
wildtype rhodopsin (see Ref. 11 for a more thorough
154 Rhodopsin E113Q Counterion Mutantanalysis). Also in E181Q, there is a partial anticipa-
tion of aMeta II-like conformation of theH1/H2/H7
network as sensed by Asp83 at −20 °C, although not
as complete as in E113Qstab. The amide I marker
band of Meta I at 1663 cm−1 is decreased similarly in
Meta I of E181Q and E113Qstab, while a concomitant
increase in the range of the Meta II marker band
around 1644 cm−1 is lacking in Meta I of E181Q, in
contrast to the Meta II precursor state of E113Qstab
stabilized at −30 °C.
The structural importance of the salt bridge of the
PSB to Glu113 becomes most obvious on the back-
ground of the activation pattern in E113Qstab PSB,
where a bound solute anion such as chloride com-
pensates for the loss of the negative charge in the
stabilization of a protonated Schiff base. This com-
pensation by the bound anion is merely electrostatic
in nature, increasing the apparent pKA of the Schiff
base by the presence of a negative countercharge.
This bound anion has no discernible structural rele-
vance and cannot mimic the structural role of the ne-
gatively charged sidechain of Glu113. This becomes
evident in the almost identical spectral evolution
during activation of E113Qstab SB and E113Qstab PSB
(Fig. 6c and d). Even the small residual differences
between both forms of E113Qstab are possibly a con-
sequence of a different polarization of the retinal-
binding pocket in the two forms rather than of a dif-
ferent structure.
Can Glu181 on EC2 compensate for Glu113? Cer-
tainly not in the dark state, as evident from the lack of
protonation of the Schiff base in the absence of sui-
table solute anions.8,9 On the basis of the results ob-
tained with the E181Q mutant, the function of the
counterion was suggested to shift, at least partially, to
Glu181 in the transition to Meta I.11,12 While the
E181Q mutant maintained the pH-dependent con-
formational equilibrium between theMeta I andMeta
II states,11 this equilibrium is shown here to be absent
from the E113Q mutant. This is presumably due to a
considerable lowering of the enthalpy change of the
transition from Meta I to Meta II by the mutational
neutralization of the PSB salt bridge, such that this
step becomes independent of the cytoplasmic proton
uptake reaction. Even in the Meta II precursor state of
E113Qstab, which can be cryo-trapped at −30 °C, the
conformation of the receptor is considerably more
evolved toward an active state conformation than in
the Meta I state of E181Q stabilized at a similar tem-
perature, as evident from the conformational changes
in the H1/H2/H7 microdomain and the amide I
marker band analysis. Notably, this distinction holds
for both E113Qstab SB and PSB.
As shown in this and in previous time-resolved
UV-visible studies,36 the SB forms of E113Q mutants
of rod rhodopsin do not produce transient photo-
intermediates with a PSB on the main activation
pathway. This implicates a quite different electro-
static environment along the path of the Schiff base in
the E113Q mutant of rod rhodopsin as compared
with the mouse UV cone pigment or the E113Q mu-
tant thereof, where a protonation of the SB in Lumi
and Meta I, respectively, has been reported.46,47In the photoproducts of the UV-absorbing SB form
of E113Qstab, a protonation of the SB is observed only
in the transition fromMeta II toMeta III, triggered by
C15=N Schiff base isomerization of the chromo-
phore from all-trans 15-anti to all-trans 15-syn.33 This
indicates that a counterion different from Glu113
stabilizes the PSB in this state. As these experiments
were performed in the absence of small solute anions
such as chloride, and using bis-tris-propane andMes
buffers with relatively bulky anions, a Meta III-
specific binding of a solute anion near the Schiff base
appears unlikely. Glu181 as the only ionizable resi-
due in the vicinity of the PSB is therefore the most
likely candidate for this counterion function in the
absence of Glu113. Does this interaction, however,
have similar structural implications as the salt bridge
between Glu113 and the PSB, which stabilizes in-
active receptor conformations? In wildtype rhodop-
sin, Meta III exists in a conformational equilibrium
between active and inactive conformations, which is
on the side of the inactive conformation except for
the very acidic pH range. Both conformations have a
PSB, despite the fact that Glu113 becomes protonated
in the active, low-pH Meta III state, as evident from
its FTIR protonation signature.35 In E113Qstab, only
the active conformation of Meta III is observed,
which indicates that Glu113 is the structural counter-
ion that stabilizes the inactive conformation of Meta
III in wildtype.
While Glu181 appears to be capable of stabilizing a
PSB in the active conformation ofMeta III inwildtype
and similarly in the E113Q mutant, this interaction
obviously does not exert the same constraints as the
Glu113/PSB salt bridge and is not able of keeping the
receptor in an inactive conformation. The PSB in the
all-trans 15-syn Meta III isomers can therefore be
stabilized either by Glu113 or Glu181, but these two
interactions have entirely different structural implica-
tions. While formation of the Glu113/PSB salt bridge
is responsible for a deactivation of the receptor in the
inactive conformation of the Meta III conformational
equilibrium, the putative interaction between the PSB
and Glu181 is clearly compatible with an active state
conformation.
These findings are depicted in the structural cartoon
shown in Fig. 9c. Glu181 is about 7 Å distant from
Glu113 in the dark state crystal structures. The sug-
gested switch of the counterion requires significant
movement of the all-trans 15-syn PSB from Glu113
toward Glu181 in the transition from the inactive to
the active conformation of Meta III. Such a transla-
tional movement of retinal of approximately 4 Å was
shown to take place during receptor activation in the
transition toMeta II in solid-stateNMR experiments.38
In the active conformation of Meta III, the retinal all-
trans 15-syn isomer presumably occupies a position
quite similar to that of the all-trans 15-anti isomer in
Meta II. This is supported by the fact that only small
changes are observed for the absorption pattern of
Glu122, positioned next to the ring of retinal, in the
transition from Meta II to the active Meta III state.
The pKA of the 15-anti Schiff base in Meta II had
been reported to be below 2.5 in the absence of small
155Rhodopsin E113Q Counterion Mutantsolute anions.31 In the active conformation of Meta
III, on the other hand, the protonated form of the 15-
syn Schiff base is stable at least up to pH 9, as probed
in the E113Qstab mutant, despite the fact that the
conformational transitions involved in the transition
from Meta II to active Meta III appear to be quite
small. This large shift of the pKA of the Schiff base
must therefore be achieved mainly by the re-orient-
ation of the Schiff base induced by the C15=N iso-
merization rather than by a large conformational
transition of the receptor. As a consistent model, we
propose in Meta II an orientation of the 15-anti Schiff
base toward the cytoplasmic side of the receptor,
away from Glu181, resulting in a low apparent pKA,
while the 15-syn Schiff base in active Meta III is
oriented toward Glu181, thereby increasing the
apparent pKA considerably. The isomerization of
the C15=N Schiff base double bond triggers this pKA
switch by translocating the Schiff base between
different environments. Such a rapid shift of pKA
induced by C15=N isomerization is consistent with
time-resolved UV-visible and FTIR experiments of
theMeta II toMeta III transition inwildtype.48 Those
experiments indicate a fast re-protonation of the
Schiff base by a local change with a time constant of
less than 5 ms. This is followed on a much longer
timescale of more than 1 s by the slower global con-
formational changes responsible for the deactivation
of the receptor in the transition to the inactive Meta
III conformation.
UV light-induced isomerization of the C15=N
Schiff base double bond inMeta II appears to depend
on the deprotonated form of the all-trans retinal Schiff
base and is not observed in a Meta IIPSB state, in
which a protonation is stabilized by the presence of
suitable solute anions.49 As rhodopsin has a pro-
tonated retinal Schiff base in the dark state, with an
absorption maximum at 500 nm, it can be photo-
activated by green light, which triggers the 11-cis 15-
anti to all-trans 15-anti isomerization of the chromo-
phore but does not cause further 15-anti to 15-syn
isomerization in Meta II absorbing at 380 nm. The
UV-absorbing E113Q counterion mutant and simi-
larly UV-absorbing cone pigments, which have an SB
in the dark state, require UV light for photoactivation.
Lengthy UV illuminationmay induce such secondary
15-anti to 15-syn isomerization in the respective Meta
II states (and possibly also earlier states), as shown
here explicitly for the E113Qstab mutant. In this
mutant pigment, the C15=N isomerization is accom-
panied by protonation of the SB and thus easily
detectable. UV-absorbing cone pigments may have a
different electrostatic environment in their chromo-
phore-binding pockets, such that C15=N isomeriza-
tion of the SB does not necessarily lead to the same
upshift of pKA. Such secondary isomerizations may
therefore go undetected by UV-visible spectroscopy.Conclusion
The study of the E113Qmutant of rhodopsin offers
interesting insight into the interplay between Glu113on H3 and Glu181 on EC2 in their contribution to the
counterion function in the dark and the photopro-
duct states. Glu181 contributes to the salt bridge
between the PSB and Glu113, and thereby to the
extraordinarily high level of stability of the dark
state. During receptor activation, this salt bridge
needs to be broken to allow re-arrangement of the
transmembrane helices, which appears to happen in
a stepwise manner by a gradual shift of the counter-
ion function from Glu113 to Glu181 in Meta I,
leading to a complete disruption in Meta II. Muta-
tional neutralization of the PSB salt bridge in the
E113Qstab mutant leads to a considerably altered ac-
tivation pathway, in which the classical pH-de-
pendent conformational equilibrium between Meta
I and Meta II is absent. Using FTIR difference spect-
roscopy and specific reporter groups in different
microdomains, the interhelical hydrogen-bonded
network between helices 1, 2, and 7 could be further
shown to adopt an active state conformation already
in aMeta II precursor state cryo-trapped at−30 °C. In
the E113Q mutant, Glu181 can therefore not com-
pensate for the lack of Glu113 on the activation
pathway. A protonation of the SB is observed only in
the transition to Meta III involving an isomerization
of the Schiff base C15=N double bond, which is
presumably stabilized by Glu181. This interaction is,
however, not sufficient for a deactivation of the
receptor, underlining the unique role of the PSB salt
bridge to Glu113 in constraining the receptor in an
inactive conformation.Materials and Methods
Sample preparation
The stabilized rhodopsinN2C/D282C and the E131Qstab
mutant N2C/D282C/E113Q were prepared by transient
expression in COS or HEK293 cells, combination with 11-
cis retinal chromophore, and purification on a 1D4 anti-
body column in 0.02% n-dodecyl-β-D-maltoside (DDM) as
described.3,28 Bothmutants were further reconstituted into
lipidmembranes. Initial attempts to purify E113Qstab in the
easily dialyzable detergent β-octyl glucoside was not
successful, recalling the importance of the PSB-Glu113
salt bridge for structural stability of the pigment. We there-
fore reconstituted pigment purified in the more stabilizing
detergent DDM into egg PC membranes with a lipid to
protein molar ratio of 200:1. Reconstitution was achieved
by extended dialysis over six days at 4 °C with a 7 kDa
cutoff against 1mMsodiumphosphate buffer, pH 6.5,with
frequent buffer changes. The resulting proteoliposomes
were collected by centrifugation. Wildtype rhodopsin was
prepared from bovine retinae, purified on a concanavalin
A column in 0.02% DDM, and reconstituted into PC mem-
branes according to published procedures50,51 in parallel
with the E113Qstab mutant pigment to ensure identical
sample conditions.
Spectra from the E181Q mutant in PC membranes were
obtained as described.11
FTIR and UV-visible experiments were performed with
sandwich samples described in detail elsewhere,29 with
0.1–0.2 nmol of recombinant pigment. Samples were equi-
librated with 40 μl of buffer before sandwiching themwith
156 Rhodopsin E113Q Counterion Mutantthe topwindow. E113Qstab SB samples were preparedwith
200 mM bis-tris-propane buffer at pH 7.5, while E113Qstab
PSB samples were prepared with 100 mMMes buffer and
100 mM NaCl at pH 5.0. Samples with wildtype pigment
were prepared correspondingly with pH 5.0 for Meta II
experiments and with pH 7.5 otherwise. Meta II and Meta
III spectraweremeasured at 10 °C,Meta I spectra at −30 °C
(−20 °C for E181Q and wildtype), Lumi at −90 °C, and
Batho at −183 °C. For H/D exchange, sample films were
equilibrated with 2H2O and dried under nitrogen before
adding the respective buffer prepared in 2H2O.
Spectroscopy
FTIR-difference spectroscopy was performed with a
Bruker Vertex FTIR spectrometer as described.52 Spectra
were accumulated over 1 min using a liquid nitrogen-cooled
mercury-cadmium-telluride (MCT) detector at a spectral
resolution of 4 cm−1. Samples were photolyzed either for
10 s with a 150 W tungsten lamp via a fiber optic and a
530 nm long-pass filter (for wildtype rhodopsin, stabilized
rhodopsin, and E113Qstab PSB) or by a 1 s near-UV
illumination using a single 10 mW UV LED (Yoldal CO.
Ltd., Taiwan)with an emission peak at 395 nm (for E113Qstab
SB). For generation of the Meta III state of E113Qstab SB, the
UV illumination was extended to 20 s. The temperature of
the samples was controlled by a circulating water-bath, a
Peltier cooling unit, or a liquid nitrogen-operated cryostat,
depending on the desired temperature. UV-visible spectro-
scopy was performed with identical samples in a Perkin-
Elmer Lambda 17 spectrophotometer equipped with a
temperature-controlled sample holder. Illumination condi-
tions were identical with those for the FTIR experiments.
Molecular models
Molecular models are based on the coordinates of the
dark state PDB 1GZM,4 of the dark state of the stabilized
N2C/D282C mutant pdb 2J4Y,3 and of the Lumi state
2HPY,6 and were prepared with software Deep View
3.753‡ and POV Ray 3.5§.Acknowledgements
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